The ETF experienced NAV adjustments across 6+ months due to dividend posting errors, eroding investor confidence. The fund's year-to-date NAV return of -10.24% significantly underperforms its benchmark index return of -7.44%, indicating suboptimal portfolio management.
Articles that tag PCR but are mainly about other companies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology